<?xml version="1.0" encoding="utf-8" ?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Viviancreative - Latest News</title>
<link href="https://news.arcnewswire.com/rss/viviancreative/latest.xml"></link>
<updated>2026-09-20T09:31:46+00:00</updated>
<id>urn:uuid:ca598ede-3a66-4224-bdf7-624b59c1e435</id>
<entry>
<title>Creative Biolabs Showcases Exosome Engineering Strategies for Targeted Delivery of CRISPR/Cas System</title>
<link href="https://news.arcnewswire.com/@viviancreative/creative-biolabs-showcases-exosome-engineering-strategies-for-targeted-delivery-of-crispr-cas-system-qjo9ciy8sitg"></link>
<id>urn:uuid:2453fc94-ba96-6824-5549-18f1f6e1f6aa</id>
<summary type="html"><![CDATA[The potential of exosomes as an alternative delivery vector for the CRISPR/Cas9 components encourages Creative Biolabs to present its exosome engineering strategies.]]></summary>
<updated>2023-06-27T01:34:19+00:00</updated>
</entry>
<entry>
<title>Creative Biolabs Catches Wind of Stem Cell-Derived Exosome Therapeutics in Stroke</title>
<link href="https://news.arcnewswire.com/@viviancreative/creative-biolabs-catches-wind-of-stem-cell-derived-exosome-therapeutics-in-stroke-jlrb7yysonlx"></link>
<id>urn:uuid:b6dead78-87dc-2e9a-2916-5f56af764cae</id>
<summary type="html"><![CDATA[Considering a recently featured article by NIH introducing the therapeutic effects of NSC-derived exosomes in cerebral ischemia, Creative Biolabs updates its service portfolio related to stem cell-derived exosomes.]]></summary>
<updated>2023-06-15T03:35:41+00:00</updated>
</entry>
<entry>
<title>Creative Biolabs Participates in Booming Exosome Manufacturing Market Growth</title>
<link href="https://news.arcnewswire.com/@viviancreative/creative-biolabs-participates-in-booming-exosome-manufacturing-market-growth-6p3w7mrb535y"></link>
<id>urn:uuid:9b2382ff-a388-4b9f-8556-ca6b6d06b390</id>
<summary type="html"><![CDATA[Creative Biolabs, a leading life science company specialized in exosome research services, has been one of the top players of growing exosome market size and trend based on its full-scale exosome sampling, analysis, and manufacturing services.]]></summary>
<updated>2022-03-07T09:34:04+00:00</updated>
</entry>
<entry>
<title>Creative Biolabs Girds Exosome Services for Displaying ACE2 Variants</title>
<link href="https://news.arcnewswire.com/@viviancreative/creative-biolabs-girds-exosome-services-for-displaying-ace2-variants-b68qeyq6j8dj"></link>
<id>urn:uuid:765df4e6-88cd-5e95-57b8-607b32140a6d</id>
<summary type="html"><![CDATA[To better aid SARS-CoV-2 drug discovery, Creative Biolabs updates its exosome services for displaying ACE2 variants on the surface of small extracellular vesicles.]]></summary>
<updated>2022-02-18T05:38:24+00:00</updated>
</entry>
</feed>